期刊文献+

艾滋病患者抗病毒督导治疗疗效分析 被引量:8

Analysis on effects of HAART from 377 Chinese AIDS
下载PDF
导出
摘要 目的:探讨提高抗病毒疗效和服药依从性,延缓病毒耐药发生的方法。方法:377名来源于同一乡村的HIV感染者,分为督导治疗组(n=134)和未督导治疗组(n=243),均给予HAART治疗,仅督导治疗组患者给予严格督导治疗。分别于治疗后第1、2、3、6、9和12个月,抽取外周血,应用PCR检测HIV-RNA载量,流式细胞仪检测CD4+、CD8+T淋巴细胞数量,血常规检测白细胞数量变化。结果:随着治疗时间的延长,2组患者外周血CD4+、CD8+T淋巴细胞及白细胞数量均逐渐上升;2组间比较,差异无统计学意义。2组患者外周血HIV-RNA载量差异有统计学意义(F组间=3.781,F时间=2.561,F交互=352.79,P﹤0.05);治疗后6、9和12个月督导治疗组高于未督导治疗组。结论:督导治疗有利于持续抗病毒疗效,延缓耐药毒株的发生。 Aim: To seek the suitable method for elevating the effects of HAART and delaying the emergence of the resistance. Methods: 377 AIDS patients from the same area were divided into the full supervision ( n = 134) and non-full supervision ( n = 134) treatment groups. All the patients were given the same HAART traerment for 12 months. At 1,2,3, 6,9,12 months after treatment,the HIV-RNA load were detected by PCR ,CD4 + ,CD8 + T cells were detected by flow cy- tometry ,and white blood cell ( WBC) were detected by routine blood test. Results: The counts of CD4 + ,CD8 + T cells elevated in the two groups ,and there were no obviously different. The HIV-RNA load between the two groups were different ( F group = 3. 781,F time = 2. 561,F interaction = 352. 791,P 0. 05) ; Non-full supervision treatment group was higher than the full supervision treatment group at 6,9,12 months after treatment. Conclusion: The full supervision treatment could delay the emergence of resistance and prolong the effect of HAART.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2013年第2期235-238,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 国家"十.五"攻关课题基金资助项目200413A719A13-05 200413A719A10 国家自然科学基金资助项目30472031
关键词 人类免疫缺陷病毒 高效逆转录病毒治疗 耐药 human immunodeficiency virus highly active antiretroviral therapy resistance
  • 相关文献

参考文献2

二级参考文献10

  • 1Ho DD,Neumann AU,Perelson AS,Chen W,Leonard JM,Markowitz M.Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection[].Nature.1995
  • 2Cunningham PH,Smith DG,Satchell C,Cooper DA,Brew B.Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid[].AIDS.2000
  • 3Vergne L,Kane CT,Laurent C,Diakhate N,Gueye NF,Gueye PM, et al.Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy[].AIDS.2003
  • 4Bartlett JA,DeMasi R,Quinn J,Moxham C,Rousseau F.Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults[].AIDS.2001
  • 5Haddad DN,Birch C,Middleton T,Dwyer DE,Cunningham AL,Saksena NK.Evidence for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells[].AIDS.2000
  • 6UK collaborative group on monitoring the transmission of HIV drug resistance.Analysis of prevalence of HIV-1 drug resistance in primary infections in the UK[].BMJ.2001
  • 7Sandstrom E,Uhnoo I,Ahlqvist-Rastad J,Bratt G,Berglund T,Gisslen M, et al.Antiretroviral treatment of human immunodeficiency virus infection: Swedish recommendations[].Scandinavian Journal of Infectious Diseases.2003
  • 8Yeni PG,Hammer SM,Carpenter CC,Cooper DA,Fischl MA,Gatell JM, et al.Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel[].The Journal of The American Medical Association.2002
  • 9Lucas GM,Chaisson RE,Moore RD.Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions[].Annals of Internal Medicine.1999
  • 10Erice A,Mayers DL,Strike DG,Sannerud KJ,McCutchan FE,Henry K, et al.Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1[].The New England Journal of Medicine.1993

共引文献18

同被引文献71

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部